These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20522078)

  • 21. Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices.
    Enzlin P; Weyers S; Janssens D; Poppe W; Eelen C; Pazmany E; Elaut E; Amy JJ
    J Sex Med; 2012 Apr; 9(4):1065-73. PubMed ID: 21492401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
    Jensen JT; Nelson AL; Costales AC
    Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling -- results of an international survey in 10 countries.
    Gemzell-Danielsson K; Cho S; Inki P; Mansour D; Reid R; Bahamondes L
    Contraception; 2012 Dec; 86(6):631-8. PubMed ID: 22770797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.
    Achilles SL; Chen BA; Lee JK; Gariepy AM; Creinin MD
    Contraception; 2015 Dec; 92(6):572-4. PubMed ID: 26297203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compliance and user satisfaction with the intra-uterine contraceptive device in Family Planning Service: the results of a survey in Fife, Scotland, August 2004.
    Tewari R; Kay VJ
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):28-37. PubMed ID: 16546814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
    Ng YW; Liang S; Singh K
    Contraception; 2009 Jan; 79(1):24-8. PubMed ID: 19041437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial.
    Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Tomas E; Tuppurainen M; Paavonen J
    BJOG; 2010 Apr; 117(5):602-9. PubMed ID: 20156209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.
    Lyus R; Lohr P; Prager S;
    Contraception; 2010 May; 81(5):367-71. PubMed ID: 20399942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levonorgestrel-releasing intrauterine system: why do some women dislike it?
    Daud S; Ewies AA
    Gynecol Endocrinol; 2008 Dec; 24(12):686-90. PubMed ID: 19172537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents.
    Paterson H; Ashton J; Harrison-Woolrych M
    Contraception; 2009 Jun; 79(6):433-8. PubMed ID: 19442778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A.
    Godfrey EM; Memmel LM; Neustadt A; Shah M; Nicosia A; Moorthie M; Gilliam M
    Contraception; 2010 Feb; 81(2):123-7. PubMed ID: 20103449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy during the use of levonorgestrel intrauterine system.
    Backman T; Rauramo I; Huhtala S; Koskenvuo M
    Am J Obstet Gynecol; 2004 Jan; 190(1):50-4. PubMed ID: 14749634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.